Literature DB >> 22325808

Community treatment of severe, refractory obsessive-compulsive disorder.

Mark J Boschen1, Lynne M Drummond.   

Abstract

Despite the existence of effective psychological and pharmacological interventions for obsessive-compulsive disorder (OCD), there are a large proportion of individuals for whom intervention is not effective. The study reports on the results of a community treatment service for individuals with treatment-refractory OCD who have not benefitted from previous cognitive behavioural or pharmacological treatment by community mental health services. A total of 205 individuals accepted for treatment by a specialist community OCD treatment service in London were provided with a combination of behavioural, cognitive, and pharmacological treatment within a specialist OCD service, with 158 completing treatment. Treatment was associated with significant reduction in clinician-rated and self-reported OCD symptoms after 12 weeks, with further reductions in OCD symptoms over a subsequent 12-week period. A significant reduction in symptoms of depression was also observed after 12 and 24 weeks. Approximately 40% of individuals treated experienced clinically significant improvement in their symptoms, with approximately 10% deemed to have recovered by the end of treatment. Our results add to previous research into refractory OCD, and provide support for the existence of specialist community treatment services which may provide assistance to individuals who have not responded to previous treatment. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325808     DOI: 10.1016/j.brat.2012.01.002

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  4 in total

1.  Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorder.

Authors:  Miquel A Fullana; Xi Zhu; Pino Alonso; Narcís Cardoner; Eva Real; Clara López-Solà; Cinto Segalàs; Marta Subirà; Hanga Galfalvy; José M Menchón; H Blair Simpson; Rachel Marsh; Carles Soriano-Mas
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

2.  Comparative Prevalence of Eating Disorders in Obsessive-Compulsive Disorder and Other Anxiety Disorders.

Authors:  Himanshu Tyagi; Rupal Patel; Fabienne Rughooputh; Hannah Abrahams; Andrew J Watson; Lynne Drummond
Journal:  Psychiatry J       Date:  2015-08-23

3.  A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects.

Authors:  Himanshu Tyagi; Annemieke M Apergis-Schoute; Harith Akram; Tom Foltynie; Patricia Limousin; Lynne M Drummond; Naomi A Fineberg; Keith Matthews; Marjan Jahanshahi; Trevor W Robbins; Barbara J Sahakian; Ludvic Zrinzo; Marwan Hariz; Eileen M Joyce
Journal:  Biol Psychiatry       Date:  2019-01-30       Impact factor: 13.382

4.  Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment.

Authors:  Gerd Kvale; Bjarne Hansen; Thröstur Björgvinsson; Tore Børtveit; Kristen Hagen; Svein Haseth; Unn Beate Kristensen; Gunvor Launes; Kerry J Ressler; Stian Solem; Arne Strand; Odile A van den Heuvel; Lars-Göran Öst
Journal:  BMC Psychiatry       Date:  2018-10-04       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.